Column Group IV GP, LP, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 42,445 shares at $13.49 ($572K) on 2022-05-26, disclosed to the SEC on 2022-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.49 | 667 | $9K | 1.6% |
| 2 | $13.49 | 19,534 | $264K | 46.0% |
| 3 | $13.49 | 19,534 | $264K | 46.0% |
| 4 | $13.45 | 89 | $1K | 0.2% |
| 5 | $13.45 | 2,621 | $35K | 6.2% |
| Total | $13.49 avg | 42,445 |
| $572K |
| 100% |
| Filing → |
| NGM | BUY | 2022-06-13 | $13.7M | — | Filing → |